advanced malignancy
Showing 1 - 25 of >10,000
Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)
Enrolling by invitation
- Cancer
- Solid Tumor
- Personalized Synthetic Long Peptide Vaccine
-
San Francisco, CaliforniaQuest Clinical Research
Feb 20, 2023
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Philadelphia, Greenville, San Antonio (AMG 820)
Completed
- Advanced Malignancy
- +5 more
- AMG 820
-
Philadelphia, Pennsylvania
- +2 more
Jan 18, 2023
Immunotherapy And Palliative Radiotherapy Combined In Advanced
Active, not recruiting
- Palliative
- +3 more
- Palliative Radiation Therapy
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Oct 1, 2021
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in United States (AMG 337)
Completed
- Advanced Malignancy
- +5 more
- AMG 337
-
Los Angeles, California
- +7 more
Nov 3, 2022
Melanoma (Skin), Solid Tumor Trial in Australia, United States (PI-88)
Completed
- Melanoma (Skin)
- Unspecified Adult Solid Tumor, Protocol Specific
-
Aurora, Colorado
- +4 more
Jun 21, 2022
Advanced Cancers Trial in Houston (Regorafenib, Cetuximab, Questionnaire)
Completed
- Advanced Cancers
- Regorafenib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 31, 2021
Advanced Cervical Cancer Trial in China (TQB2858 injection)
Recruiting
- Advanced Cervical Cancer
- TQB2858 injection
-
Nanning, Guangxi Zhuang Autonomous Region, China
- +16 more
Dec 9, 2021
Cancer Trial in Beijing (LVGN7409)
Recruiting
- Cancer
- LVGN7409
-
Beijing, Beijing, ChinaCenter Hospital Chinese Academy of Medical Sciences
Dec 7, 2021
Cancer Trial in Houston (LVGN7409)
Recruiting
- Cancer
- LVGN7409
-
Houston, TexasMD Anderson Cancer Center
Apr 4, 2022
Advanced Solid Tumor Malignancy Trial in Ghent (KBA1412, Pembrolizumab)
Recruiting
- Advanced Solid Tumor Malignancy
-
Ghent, BelgiumUniversity Hospital Ghent
Aug 11, 2022
Advanced Malignancy Trial in Changchun (durvalumab, tremelimumab + durvalumab)
Completed
- Advanced Malignancy
- durvalumab
- tremelimumab + durvalumab
-
Changchun, China
- +1 more
Aug 12, 2021
Cancer, Solid Tumor, Hematologic Malignancy Trial in Hangzhou (engineered red blood cell WTX212)
Recruiting
- Cancer
- +2 more
- engineered red blood cell WTX212
-
Hangzhou, Zhejiang, ChinaZhejiang Provincial People'S Hospital
Jan 21, 2023
Distress Associated With Coronavirus Disease 2019 and Telehealth
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +6 more
- Survey Administration
-
Houston, TexasM D Anderson Cancer Center
Sep 16, 2022
Cancer Trial in Houston (LVGN6051)
Recruiting
- Cancer
- LVGN6051
-
Houston, TexasMD Anderson Cancer Center
Nov 18, 2021
Cancer, End Stage Cancer, Malignancy Trial in Baltimore (Community Health Worker (CHW) based palliative care)
Enrolling by invitation
- Cancer
- +3 more
- Community Health Worker (CHW) based palliative care
-
Baltimore, MarylandJohns Hopkins University School of Medicine
Nov 8, 2022
Hematologic Malignancy Trial in Boston (Home Transfusion Program Components)
Not yet recruiting
- Hematologic Malignancy
- Home Transfusion Program Components
-
Boston, MassachusettsDana-Farber Cancer Institute
Aug 18, 2022
Molecular Services and EMR-Lab Integration Application for
Not yet recruiting
- Advanced Cancer
- +2 more
- Comprehensive Genomic Profile testing; ELIA software; Molecular Genetic Pathologist consultation
- limited genetic testing or no testing
-
Rock Hill, South CarolinaCarolina Blood and Cancer Care Associates
Oct 18, 2023
PelvEx 4: Advanced Pelvic Malignancy and Role of
Not yet recruiting
- Multidisciplinary Communication
- +4 more
- No specific intervention; cases are retrospective and patients have already been treated.
-
Dublin, IrelandSt. Vincent's Hospital
Oct 12, 2021
HPV-Related Cervical Carcinoma, HPV-Related Malignancy, Cervical Cancer Trial (VB10.16, Atezolizumab Injection [Tecentriq],
Not yet recruiting
- HPV-Related Cervical Carcinoma
- +2 more
- VB10.16
- +2 more
- (no location specified)
Oct 24, 2023
Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)
Recruiting
- Solid Tumor
- Hematological Malignancy
-
East Melbourne, Victoria, Australia
- +4 more
Jan 11, 2023